Triple valve repair in children with rheumatic heart disease: long-term experience

Patrick O Myers1, Mustafa Cikirikcioglu, Cécile Tissot

  • 1Division of Cardiovascular Surgery, Geneva University Hospitals, Geneva, Switzerland. patrick.myers@hcuge.ch

Insights

Triple valve repair in rheumatic children showed no early deaths and satisfactory mid-term results. However, 40% of patients required reoperation within 15 years, indicating a palliative approach for growth.

Area of Science:

  • Pediatric Cardiac Surgery
  • Rheumatic Heart Disease
  • Valvular Heart Disease

Background:

  • Triple valve replacement in children yields poor outcomes.
  • Limited data exist on triple valve repair in pediatric rheumatic heart disease.
  • This study reports long-term results of combined aortic, mitral, and tricuspid valve repair in children.

Purpose of the Study:

  • To evaluate the long-term efficacy of triple valve repair in rheumatic children.
  • To assess the need for reoperation and survival rates after triple valve repair.
  • To determine if triple valve repair is a viable palliative strategy in pediatric patients.

Main Methods:

  • Ten children with severe rheumatic aortic, mitral, and tricuspid regurgitation underwent triple valve repair.
  • Aortic valve repair utilized tailored cusp extension.
  • Mitral and tricuspid valves were repaired using ring annuloplasty and Carpentier's techniques.

Main Results:

  • No early deaths occurred in the study cohort.
  • Median follow-up was 58 months, with no late deaths.
  • Forty percent of patients (4/10) required reoperation at a median of three years due to valve failure.

Conclusions:

  • Triple valve repair offers satisfactory initial and mid-term outcomes in rheumatic children.
  • A significant long-term reoperation rate necessitates consideration of this approach as palliative.
  • This strategy allows for patient growth and subsequent placement of larger valves during eventual replacement.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...